Vaxil Bio Stock Working Capital
VXL Stock | CAD 0.01 0.00 0.00% |
Vaxil Bio fundamentals help investors to digest information that contributes to Vaxil Bio's financial success or failures. It also enables traders to predict the movement of Vaxil Stock. The fundamental analysis module provides a way to measure Vaxil Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxil Bio stock.
Last Reported | Projected for Next Year | ||
Net Working Capital | 891 K | 573.9 K | |
Change In Working Capital | -327 K | -310.6 K |
Vaxil | Working Capital |
Vaxil Bio Company Working Capital Analysis
Vaxil Bio's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Vaxil Bio Working Capital | 891 K |
Most of Vaxil Bio's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxil Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vaxil Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Vaxil Bio is extremely important. It helps to project a fair market value of Vaxil Stock properly, considering its historical fundamentals such as Working Capital. Since Vaxil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vaxil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vaxil Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
Vaxil Capital Lease Obligations
Capital Lease Obligations |
|
As per the company's disclosures, Vaxil Bio has a Working Capital of 891 K. This is 99.79% lower than that of the Biotechnology sector and 99.83% lower than that of the Health Care industry. The working capital for all Canada stocks is 99.94% higher than that of the company.
Vaxil Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vaxil Bio from analyzing Vaxil Bio's financial statements. These drivers represent accounts that assess Vaxil Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaxil Bio's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 3.1M | 30.5M | 10.2M | 2.7M | 2.5M | 3.5M | |
Enterprise Value | 3.0M | 29.0M | 8.0M | 1.2M | 1.1M | 1.1M |
Vaxil Fundamentals
Return On Equity | -0.2 | ||||
Return On Asset | -0.1 | ||||
Current Valuation | 449.79 K | ||||
Shares Outstanding | 136.98 M | ||||
Shares Owned By Insiders | 8.16 % | ||||
Shares Owned By Institutions | 0.01 % | ||||
Number Of Shares Shorted | 3.73 K | ||||
Price To Earning | (1.40) X | ||||
Price To Book | 2.39 X | ||||
EBITDA | (252) | ||||
Net Income | (254 K) | ||||
Cash And Equivalents | 307 K | ||||
Total Debt | 85 K | ||||
Debt To Equity | 11.20 % | ||||
Current Ratio | 1.07 X | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (561 K) | ||||
Short Ratio | 1.77 X | ||||
Beta | -3.67 | ||||
Market Capitalization | 1.37 M | ||||
Total Asset | 976 K | ||||
Retained Earnings | (19.36 M) | ||||
Working Capital | 891 K | ||||
Net Asset | 976 K |
About Vaxil Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.